Invesco’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Sell |
59,598
-146,165
| -71% | -$4.57M | ﹤0.01% | 2594 |
|
|
2025
Q1 | $6.9M | Sell |
205,763
-3,791
| -2% | -$127K | ﹤0.01% | 1991 |
|
|
2024
Q4 | $8.21M | Sell |
209,554
-6,268
| -3% | -$246K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $8.5M | Sell |
215,822
-650,963
| -75% | -$25.6M | ﹤0.01% | 1927 |
|
|
2024
Q2 | $33.8M | Sell |
866,785
-182,741
| -17% | -$7.13M | 0.01% | 1177 |
|
|
2024
Q1 | $45.2M | Buy |
1,049,526
+329,808
| +46% | +$14.2M | 0.01% | 1085 |
|
|
2023
Q4 | $33.2M | Buy |
719,718
+3,415
| +0.5% | +$157K | 0.01% | 1188 |
|
|
2023
Q3 | $24.5M | Buy |
716,303
+16,318
| +2% | +$557K | 0.01% | 1248 |
|
|
2023
Q2 | $26.9M | Buy |
699,985
+683,514
| +4,150% | +$26.3M | 0.01% | 1201 |
|
|
2023
Q1 | $589K | Buy |
+16,471
| New | +$589K | ﹤0.01% | 3157 |
|
|
2022
Q2 | – | Sell |
-198,701
| Closed | -$6.07M | – | 4118 |
|
|
2022
Q1 | $6.07M | Sell |
198,701
-95,399
| -32% | -$2.92M | ﹤0.01% | 2268 |
|
|
2021
Q4 | $9.19M | Buy |
+294,100
| New | +$9.19M | ﹤0.01% | 2053 |
|
|
2020
Q1 | – | Sell |
-12,410
| Closed | -$163K | – | 3679 |
|
|
2019
Q4 | $163K | Buy |
12,410
+1,865
| +18% | +$24.5K | ﹤0.01% | 3503 |
|
|
2019
Q3 | $95K | Sell |
10,545
-3,313
| -24% | -$29.8K | ﹤0.01% | 3578 |
|
|
2019
Q2 | $137K | Buy |
+13,858
| New | +$137K | ﹤0.01% | 3611 |
|